Submitted by Anonymous (not verified) on 13 September 2024 - 8:46
Opinion/decision on a Paediatric investigation plan (PIP): Imfinzi, durvalumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0301/2023
Source: